Chan SL - Search Results

1

Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond.

Feng MY, Chan LL, Chan SL. Feng MY, et al. Among authors: chan ll, chan sl. Curr Oncol. 2022 Aug 4;29(8):5489-5507. doi: 10.3390/curroncol29080434. Curr Oncol. 2022. PMID: 36005172 Free PMC article. Review.

2

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

Wong VW, Chan SL, Mo F, Chan TC, Loong HH, Wong GL, Lui YY, Chan AT, Sung JJ, Yeo W, Chan HL, Mok TS. Wong VW, et al. Among authors: chan tc, chan hl, chan at, chan sl. J Clin Oncol. 2010 Apr 1;28(10):1660-5. doi: 10.1200/JCO.2009.26.2675. Epub 2010 Mar 1. J Clin Oncol. 2010. PMID: 20194845

3

Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.

Zhou Q, Lui VW, Lau CP, Cheng SH, Ng MH, Cai Y, Chan SL, Yeo W. Zhou Q, et al. Among authors: chan sl. Biochem Pharmacol. 2012 May 1;83(9):1146-58. doi: 10.1016/j.bcp.2012.01.013. Epub 2012 Jan 20. Biochem Pharmacol. 2012. PMID: 22285225

4

Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma.

Abou-Alfa GK, Puig O, Daniele B, Kudo M, Merle P, Park JW, Ross P, Peron JM, Ebert O, Chan S, Poon TP, Colombo M, Okusaka T, Ryoo BY, Minguez B, Tanaka T, Ohtomo T, Ukrainskyj S, Boisserie F, Rutman O, Chen YC, Xu C, Shochat E, Jukofsky L, Reis B, Chen G, Di Laurenzio L, Lee R, Yen CJ. Abou-Alfa GK, et al. J Hepatol. 2016 Aug;65(2):289-95. doi: 10.1016/j.jhep.2016.04.004. Epub 2016 Apr 13. J Hepatol. 2016. PMID: 27085251 Clinical Trial.

5

A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma.

Chan SL, Yeo W, Mo F, Chan AWH, Koh J, Li L, Hui EP, Chong CCN, Lai PBS, Mok TSK, Yu SCH. Chan SL, et al. Among authors: chan awh. Cancer. 2017 Oct 15;123(20):3977-3985. doi: 10.1002/cncr.30825. Epub 2017 Jun 22. Cancer. 2017. PMID: 28640364 Free article. Clinical Trial.

6

Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.

Chong CC, Chan AW, Wong J, Chu CM, Chan SL, Lee KF, Yu SC, To KF, Johnson P, Lai PB. Chong CC, et al. Among authors: chan sl, chan aw. Surgeon. 2018 Jun;16(3):163-170. doi: 10.1016/j.surge.2017.07.003. Epub 2017 Aug 12. Surgeon. 2018. PMID: 28807570

7

Ablative Chemoembolization for Hepatocellular Carcinoma: A Prospective Phase I Case-Control Comparison with Conventional Chemoembolization.

Yu SCH, Chan SL, Lee KF, Hui JWY, Hui EP, Chu CM, Chan AW, Cheung S, Li L, Wong J, Yeo WMM. Yu SCH, et al. Among authors: chan sl, chan aw. Radiology. 2018 Apr;287(1):340-348. doi: 10.1148/radiol.2017170154. Epub 2017 Dec 22. Radiology. 2018. PMID: 29272212 Clinical Trial.

8

Treatment of advanced hepatocellular carcinoma: immunotherapy from checkpoint blockade to potential of cellular treatment.

Siu EH, Chan AW, Chong CC, Chan SL, Lo KW, Cheung ST. Siu EH, et al. Among authors: chan sl, chan aw. Transl Gastroenterol Hepatol. 2018 Nov 7;3:89. doi: 10.21037/tgh.2018.10.16. eCollection 2018. Transl Gastroenterol Hepatol. 2018. PMID: 30603725 Free PMC article. Review.

9

Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.

Li L, Chan SL, Mo F, Hui EP, Koh J, Chan AK, Tang NL, Chu CM, Hui J, Lee KF, Yu S, Yeo W. Li L, et al. Among authors: chan ak, chan sl. Qual Life Res. 2019 Sep;28(9):2597-2607. doi: 10.1007/s11136-019-02190-0. Epub 2019 Apr 29. Qual Life Res. 2019. PMID: 31037590

10

Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.

Liu M, Zhou J, Liu X, Feng Y, Yang W, Wu F, Cheung OK, Sun H, Zeng X, Tang W, Mok MTS, Wong J, Yeung PC, Lai PBS, Chen Z, Jin H, Chen J, Chan SL, Chan AWH, To KF, Sung JJY, Chen M, Cheng AS. Liu M, et al. Among authors: chan awh, chan sl. Gut. 2020 Feb;69(2):365-379. doi: 10.1136/gutjnl-2018-317257. Epub 2019 May 10. Gut. 2020. PMID: 31076403

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

670 results

Search Page